TTC8 Polyclonal Antibody, AbBy Fluor-555 Conjugated, BF555, Rabbit

Catalog Number: BSS-BS-11510R-BF555
Article Name: TTC8 Polyclonal Antibody, AbBy Fluor-555 Conjugated, BF555, Rabbit
Biozol Catalog Number: BSS-BS-11510R-BF555
Supplier Catalog Number: bs-11510R-BF555
Alternative Catalog Number: BSS-BS-11510R-BF555-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: FC, IF, WB
Species Reactivity: Human, Mouse
Conjugation: BF555
Alternative Names: Bardet Biedl syndrome 8 protein, Bardet Biedl syndrome type 8, Bardet-Biedl syndrome 8 protein, BBS8, Tetratricopeptide repeat domain 8, Tetratricopeptide repeat protein 8, TPR repeat protein 8, TTC 8, Ttc8, TTC8_HUMAN.
Bardet-Biedl syndrome (BBS) is a pleiotropic genetic disorder characterized by obesity, photoreceptor degeneration, polydactyly, hypogenitalism, renal abnormalities, and developmental delay. BBS patients also have an increased risk of developing diabetes, hypertension, and congenital heart defects. BBS is a heterogeneous disorder mapping to eight genetic loci and encoding eight proteins, BBS1-BBS8. Five BBS proteins encode basal body or cilia proteins, suggesting that BBS is a ciliary dysfunction disorder. BBS2 contains two overlapping genes: BBS2L1 and BBS2L2. BBSL1 was re-named BBS7, whereas BBS2L2 independently funcitons as BBS1. BBS7 contains 672 amino acids and is expressed at low to moderate levels in most human tissues.
Clonality: Polyclonal
Concentration: 1ug/ul
Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human BBS8
Target: TTC8
Application Dilute: WB(1:300-5000), FCM(1:20-100), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)